NuVasive Top Management

NUVADelisted Stock  USD 42.35  0.85  1.97%   
NuVasive employs about 3 K people. The company is managed by 10 executives with a total tenure of roughly 15 years, averaging almost 1.0 years of service per executive, having 300.0 employees per reported executive. Analysis of NuVasive's management performance can provide insight into the company performance.
Christopher Barry  CEO
CEO, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

NuVasive Management Team Effectiveness

The company has return on total asset (ROA) of 0.0242 % which means that it generated a profit of $0.0242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0331 %, meaning that it created $0.0331 on every $100 dollars invested by stockholders. NuVasive's management efficiency ratios could be used to measure how well NuVasive manages its routine affairs as well as how well it operates its assets and liabilities.

NuVasive Workforce Comparison

NuVasive is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 43,686. NuVasive holds roughly 3,000 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

NuVasive Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NuVasive insiders, such as employees or executives, is commonly permitted as long as it does not rely on NuVasive's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, NuVasive insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

NuVasive Notable Stakeholders

A NuVasive stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NuVasive often face trade-offs trying to please all of them. NuVasive's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NuVasive's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About NuVasive Management Performance

The success or failure of an entity such as NuVasive often depends on how effective the management is. NuVasive management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NuVasive management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NuVasive management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. Nuvasive operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2900 people.
Please note, the presentation of NuVasive's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NuVasive's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NuVasive's management manipulating its earnings.

NuVasive Workforce Analysis

Traditionally, organizations such as NuVasive use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NuVasive within its industry.

NuVasive Manpower Efficiency

Return on NuVasive Manpower

Revenue Per Employee400.6K
Revenue Per Executive120.2M
Net Income Per Employee13.5K
Net Income Per Executive4M
Working Capital Per Employee49.7K
Working Capital Per Executive14.9M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in NuVasive Stock

If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios